Skip to main content

Site notifications

Guideline on the clinical investigation of medicinal products for the treatment of Duchenne and Becker muscular dystrophy

We have adopted this International Scientific Guideline - EMA/CHMP/236981/2011, Corr. 1. 

Last updated

Help us improve the Therapeutic Goods Administration site